Who
Adrian Senderowicz
Director
Company insider
Files Form 4 as: Director, Puma Biotechnology; Chief Medical Officer, Constellation Pharmaceuticals; SVP, Chief Medical Officer, Dare Bioscience; Chief Medical Officer, Ignyta.
In numbers
- Trades disclosed
- 48
- Buys
- 0
- Sells
- 9
- Bought
- $0
- Sold
- $2.5M
- Companies
- 4
- Companies where not an officer
- 1
- First trade
- 11 Aug 2014
- Last trade
- 12 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jun 2026filed 15 Jun 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $194K27,000 at $7.20 | filing |
| 12 Jun 2026filed 15 Jun 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $194K27,000 at $7.20 | filing |
| 11 Jun 2026filed 15 Jun 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 13 Jun 2025filed 17 Jun 2025 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $92K27,000 at $3.40 | filing |
| 11 Jun 2025filed 13 Jun 2025 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 18 Jun 2024filed 21 Jun 2024 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 13 Jun 2024filed 17 Jun 2024 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $90K27,000 at $3.33 | filing |
| 13 Jun 2023filed 15 Jun 2023 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $93K27,000 at $3.45 | filing |
| 13 Jun 2023filed 15 Jun 2023 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 16 Jun 2022filed 21 Jun 2022 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $73K27,858 at $2.63 | filing |
| 14 Jun 2022filed 17 Jun 2022 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 15 Jun 2021filed 17 Jun 2021 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Code A | —27,858 at $0.00 | filing |
| 11 Jun 2021filed 15 Jun 2021 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $458K40,993 at $11.17 | filing |
| 11 Jun 2020filed 15 Jun 2020 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $99K10,000 at $9.89 | filing |
| 9 Jun 2020filed 11 Jun 2020 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Code A | —25,748 at $0.00 | filing |
| 12 May 2020filed 13 May 2020 | Constellation Pharmaceuticalsoption or derivative | SEC FORM 4 Code M | —9,357 at $0.00 | filing |
| 12 May 2020filed 13 May 2020 | Constellation Pharmaceuticals | SEC FORM 4 Code M | $52K9,357 at $5.51 | filing |
| 12 May 2020filed 13 May 2020 | Constellation Pharmaceuticals | SEC FORM 4 Sold | $470K9,357 at $50.18 | filing |
| 14 Feb 2020filed 18 Feb 2020 | Constellation Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
News
Head to Head Contrast: Aurinia Pharmaceuticals (NASDAQ:AUPH) & Puma Biotechnology (NASDAQ:PBYI)PBYI · dailypolitical.com · 7 Oct 2026
0 headlines in the last 90 days name Adrian Senderowicz; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.